Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

211At and 211At-labeled radiopharmaceuticals for targeted alpha therapy

´ëÇѹæ»ç¼ºÀǾàÇ°ÇÐȸÁö 2018³â 4±Ç 2È£ p.99 ~ 105
°­Ãæ¸ð, À̱³Ã¶, ÀÌ¿ëÁø,
¼Ò¼Ó »ó¼¼Á¤º¸
°­Ãæ¸ð ( Kang Choong-Mo ) 
Korea Institute of Radiological and Medical Sciences Division of Applied RI

À̱³Ã¶ ( Lee Kyo-Chul ) 
Korea Institute of Radiological and Medical Sciences Division of Applied RI
ÀÌ¿ëÁø ( Lee Yong-Jin ) 
Korea Institute of Radiological and Medical Sciences Division of Applied RI

Abstract


211At is an alpha emitting radionuclide, which can be produced using cyclotron with alpha beam. In addition, its strong linear energy transfer and iodine-like chemistry make that 211At is one of the most attractive radionuclide in the field of targeted alpha therapy. In this review, production, labeling, and radiopharmaceuticals of 211At will be discussed

Å°¿öµå

211At; Astatine; Targeted alpha therapy; Radiotherapy; Alpha particle

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

µîÀçÀú³Î Á¤º¸

KCI